In summary, up‐regulation of METTL14 suppresses glycolysis by down‐regulating SLC2A3 and PGAM1, thus impeding Warburg effect of p53‐WT CRC cells, sequentially attenuating CRC tumorigenesis in the context of wild‐type p53 status. Here, METTL14 is linked to colorectal carcinoma.